Cancer Institute A national cancer institute
designated cancer center

Heike Daldrup-Link

Publication Details

  • [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].

    Häussler MD, Rummeny EJ, Raufhake C, Blasius S, Lindner N, Daldrup HE, Reimer P, Peters PE. Radiologe. 1996; 36 (2): 148-52

    To evaluate the efficacy of high-dose Gd-DTPA-BMA (gadodiamide, Omniscan) as a contrast for magnetic resonance imaging of malignant bone tumors and the use of high-dose dynamic studies for predicting the response to pre-operative chemotherapy.

    PubMedID: 8867432

Stanford Medicine Resources:

Footer Links: